Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

PRP treatment for hair loss shows promise, with 58% of patients satisfied and most noticing improvement within 6 months.

In this study, Autologous Platelet Rich Plasma Concentrated Spray (Keratogrow®) applied to the scalp twice daily for three months showed clinical improvement in hair regrowth and density compared to baseline.

This paper discusses the recent online debate over the use of PRP in hair restoration but provides no new findings.

This study compared microneedling combined with platelet-rich plasma and microneedling with minoxidil for treating androgenetic alopecia in men, finding both approaches effectively improved hair density and alopecia grade.

This commentary reviews clinical trials on platelet-rich plasma treatments for androgenetic alopecia and emphasizes the need for standardized preparation methods and concentrations; it reports no new clinical results.

This article reviews the use of autologous platelet-rich plasma (PRP) in hair restoration, discussing its potential benefits for follicle health and regeneration, but it reports no new clinical findings.

This article questions the effectiveness of platelet-rich plasma for treating alopecia areata and presents no new clinical results.

This study concluded that two different pharmaceutical formulations of finasteride were bioequivalent in terms of rate and extent of absorption based on pharmacokinetic evaluations in a randomized crossover study with 38 volunteers.

This case report describes a 2-month-old infant with a severe seborrhea-like skin eruption and respiratory distress, similar to symptoms that led to a sibling's death from Gram-negative septicemia.

In this study, photodynamic therapy combined with platelet-rich plasma showed potential for greater efficacy than photodynamic therapy alone in treating androgenic alopecia, with both approaches improving hair density without serious side effects.

This study found that autologous non-activated platelet-rich plasma (A-PRP) was effective and safe for treating androgenetic alopecia, showing long-term improvement in hair density, thickness, and count.

This study found that in individuals with alopecia areata, intralesional Triamcinolone therapy led to significantly greater reduction in disease severity, measured by SALT scores, compared to autologous platelet-rich plasma treatment over a 24-week period.

In this prospective study, combining photodynamic therapy with PRP therapy significantly improved hair growth, quality of hair, and quality of life in women with acute telogen effluvium, compared to using each therapy alone.

In this study, a 26-year-old woman with polycystic ovarian disease and advanced hair loss (Ludwig Grade III) showed reduced hair shedding and improved hair density after four sessions of platelet-rich plasma combined with microneedling, with no reported adverse effects.

In this study, a 26-year-old woman with polycystic ovarian disease and severe hair loss showed reduced hair shedding and improved hair density following four sessions of platelet-rich plasma combined with microneedling, with no adverse effects reported.

This study found that growth factor concentrate injections combined with topical minoxidil in androgenetic alopecia patients led to similar hair regrowth outcomes as platelet-rich plasma, with lower reported pain.

This study found that platelet-rich plasma showed similar efficacy to intralesional triamcinolone acetonide for treating mild patch-type alopecia areata, offering a potential alternative with fewer steroid-related side effects.

This review discusses the process and benefits of Platelet-Rich Plasma therapy for hair restoration, emphasizing its safety and potential for encouraging hair growth, but reports no new clinical results.

This study from PRP Bristol suggests that PRP therapy may stimulate hair growth by revitalizing dormant follicles, noting its rising popularity as a non-surgical option for hair restoration.

This article reports that PRP therapy shows promise as a safe and effective non-surgical treatment for hair loss, suitable for those with early to moderate androgenetic alopecia.

This overview of PRP Bristol clinics explains the growing popularity of Platelet-Rich Plasma therapy as a non-surgical treatment for early-stage hair loss, detailing its process, benefits, and suitability for individuals with androgenetic alopecia.

This study found that Platelet-Rich Plasma (PRP) stimulated human hair growth more effectively than other tested culture media in vitro.

This review explores the evidence for platelet-rich plasma, exosomes, and other regenerative therapies as adjuncts in hair transplantation, finding that PRP has the most support, but highlights the need for standardization and transplantation-specific studies.

In this study, using EMLA cream did not adequately control pain during and after scalp PRP injections for androgenetic alopecia, with anxiety and younger age linked to higher pain levels.

This study found that combining oxygen-enriched PRP with minoxidil significantly improved hair density, hair diameter, and follicular density in patients with androgenetic alopecia compared to minoxidil alone, with higher satisfaction scores and only mild, transient adverse effects.

This study found that combining platelet-rich plasma with topical minoxidil improved hair density and patient satisfaction in androgenetic alopecia patients more than minoxidil alone, with no serious adverse events reported.

This study found that dogs with alopecia treated with platelet-rich plasma in addition to conventional therapy experienced faster hair regrowth, better coat quality, and higher recovery rates compared to conventional therapy alone.

This study found that periodic intratesticular PRP administration may slightly enhance testicular development in male lambs, indicated by increased testicular blood flow, length, and reduced resistance index compared to saline.

In this study, both platelet-rich plasma gel and 1% phenytoin cream showed comparable results for wound healing in diabetic foot ulcers in rats, with PRP providing slightly advanced histological improvements; however, the differences were not statistically significant.